Applied Health Economics and Health Policy

2008 - 2025

Current editor(s): Timothy Wrightson

From Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 10, issue 6, 2012

Insensitivity to Scope in Contingent Valuation Studies pp. 361-363

Jennifer Whitty

Inclusion of Compliance and Persistence in Economic Models pp. 365-379

Ananth Kadambi, Robert Leipold, Anuraag Kansal, Sonja Sorensen and Denis Getsios

Cost Effectiveness of Guanfacine Extended-Release versus Atomoxetine for the Treatment of Attention-Deficit/Hyperactivity Disorder pp. 381-395

M. Erder, Jipan Xie, James Signorovitch, Kristina Chen, Paul Hodgkins, Mei Lu, Eric Wu and Vanja Sikirica

Insensitivity to Scope in Contingent Valuation Studies pp. 397-405

Rikke Søgaard, Jes Lindholt and Dorte Gyrd-Hansen

What Explains Willingness to Pay for Smoking-Cessation Treatments —Addiction Level, Quit-Rate Effectiveness or the Opening Bid? pp. 407-415

Jan Olsen, Ole Rogeberg and Knut Stavem

Healthcare Costs Associated with Change in Body Mass Index in Patients with Type 2 Diabetes Mellitus in Spain pp. 417-430

Tatiana Dilla, Amparo Valladares, Claudia Nicolay, Javier Salvador, Jesús Reviriego and María Costi

Economic Implications of Rasburicase Treatment in Adult Patients with Tumour Lysis Syndrome pp. 431-440

Michael Eaddy, Brian Seal, Krishna Tangirala, Elizabeth Hackney Davies and Ken O’Day

Do Higher-Priced Generic Medicines Enjoy a Competitive Advantage Under Reference Pricing? pp. 441-451

Jaume Puig-Junoy

Volume 10, issue 5, 2012

Alcohol Reform in Viet Nam pp. 285-287

Nguyen Tam, Christopher Doran, Peter Hill and Michael Dunne

Is More Expensive Medical Technology Better? pp. 289-293

Jeffrey Voigt and Michael Mosier

NICE Medical Technologies Guidance pp. 295-297

Bruce Campbell and Mark Campbell

PleurX Peritoneal Catheter Drainage System for Vacuum-Assisted Drainage of Treatment-Resistant, Recurrent Malignant Ascites pp. 299-308

Judith White and Grace Carolan-Rees

Lifetime Productivity Losses Associated with Obesity Status in Early Adulthood pp. 309-317

Kristian Neovius, Clas Rehnberg, Finn Rasmussen and Martin Neovius

Estimating Incremental Costs with Skew pp. 319-329

Linnea Polgreen and John Brooks

Clopidogrel versus Aspirin in Patients with Atherothrombosis pp. 331-342

Georgia Kourlaba, Vassilis Fragoulakis and Nikos Maniadakis

Work Productivity and Healthcare Resource Utilization Outcomes for Patients on Etanercept for Moderate-to-Severe Plaque Psoriasis pp. 343-353

Ronald Vender, Charles Lynde, Vincent Ho, Dina Chau and Melanie Poulin-Costello

Five-Year Evolution of Drug Prescribing in a University Adult Intensive Care Unit pp. 355-358

Christine Carron, Pierre Voirol, Philippe Eggimann, André Pannatier, René Chioléro and Jean-Blaise Wasserfallen

Volume 10, issue 4, 2012

A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing pp. 217-225

Ulf Persson, Johanna Svensson and Billie Pettersson

Economic Consequences of the Demography of MRSA Patients and the Impact of Broad-Spectrum Antimicrobials pp. 227-234

Klaus Kaier and S. Moog

Cost Effectiveness of Drug-Eluting Stents in Acute Myocardial Infarction Patients in Germany pp. 235-248

Michael Bäumler, Tom Stargardt, Jonas Schreyögg and Reinhard Busse

Resource Utilization and Outcomes in Patients with Atrial Fibrillation pp. 249-259

Rachael Boggon, Gregory Lip, Arlene Gallagher and Tjeerd Staa

Economic Evaluation of Clopidogrel in Acute Coronary Syndrome Patients without ST-Segment Elevation in Greece pp. 261-271

Georgia Kourlaba, Vassilis Fragoulakis and Nikos Maniadakis

Cost-Effectiveness Analysis of Treatments for Vertebral Compression Fractures pp. 273-284

Avram Edidin, Kevin Ong, Edmund Lau, Jordana Schmier, Jason Kemner and Steven Kurtz

Volume 10, issue 3, 2012

Economic evaluations of adult weight management interventions pp. 145-162

Ulla K. Griffiths, Benedict Anigbogu and Kiran Nanchahal

Economic evaluations of adult weight management interventions pp. 145-162

Ulla Griffiths, Benedict Anigbogu and Kiran Nanchahal

Direct healthcare costs of osteoporosis-related fractures in managed care patients receiving pharmacological osteoporosis therapy pp. 163-173

Hema N. Viswanathan, Jeffrey R. Curtis, Jingbo Yu, Jeffrey White, Bradley S. Stolshek, Claire Merinar, Akhila Balasubramanian, Joel D. Kallich, John L. Adams and Sally W. Wade

Direct healthcare costs of osteoporosis-related fractures in managed care patients receiving pharmacological osteoporosis therapy pp. 163-173

Hema Viswanathan, Jeffrey Curtis, Jingbo Yu, Jeffrey White, Bradley Stolshek, Claire Merinar, Akhila Balasubramanian, Joel Kallich, John Adams and Sally Wade

Cost effectiveness of prostacyclins in pulmonary arterial hypertension pp. 175-188

Antonio Roman, Joan A. Barberà, Pilar Escribano, Maria L. Sala, Laia Febrer, Itziar Oyagüez, Eliazar Sabater and Miguel Á. Casado

Cost effectiveness of prostacyclins in pulmonary arterial hypertension pp. 175-188

Antonio Roman, Joan Barberà, Pilar Escribano, Maria Sala, Laia Febrer, Itziar Oyagüez, Eliazar Sabater and Miguel Casado

National health insurance reform in South Africa pp. 189-200

Okore Apia Okorafor

National health insurance reform in South Africa pp. 189-200

Okore Okorafor

Cost-effectiveness analysis of early versus non-early intervention in acute migraine based on evidence from the ‘Act when Mild’ study pp. 201-215

John Slof

Volume 10, issue 2, 2012

Using the economics of certification to improve the safety and quality of male circumcision in developing countries pp. 77-85

Michael Richards

Evaluating the epidemiology and morbidity burden associated with human papillomavirus in Israel pp. 87-97

Oren Shavit, Raanan Raz, Michal Stein, Gabriel Chodick, Eduardo Schejter, Yehuda Ben-David, Raanan Cohen, Daphna Arbel and Varda Shalev

Understanding consumer preferences in the context of managed competition pp. 99-111

Antonio Trujillo, Fernando Ruiz, John Bridges, Jeannette Amaya, Christine Buttorff and Angélica Quiroga

Insights from triangulation of two purchase choice elicitation methods to predict social decision making in healthcare pp. 113-126

Jennifer Whitty, Sharyn Rundle-Thiele and Paul Scuffham

A cost-utility analysis of cinacalcet in secondary hyperparathyroidism in five European countries pp. 127-138

Sergio Iannazzo, Michela Carsi and Silvia Chiroli

Budget impact analysis of switching to darunavir/ritonavir monotherapy for HIV-infected people in Spain pp. 139-141

Juan Pasquau, Joana Gostkorzewicz, Francisco Ledesma, Anne Anceau, Andrew Hill and Christiane Moecklinghoff

The need for measurement of efficiency in Greek primary healthcare pp. 143-144

Nikolaos Oikonomou, Yannis Tountas and John Kyriopoulos

Volume 10, issue 1, 2012

Triangulating health expenditure estimates from different data sources in developing countries pp. 1-13

Christian Lorenz

Intra-operative vs pre-operative endoscopic sphincterotomy in patients with gallbladder and common bile duct stones pp. 15-29

Kurinchi Gurusamy, Edward Wilson, Andrew Burroughs and Brian Davidson

The role of health economics in alcohol policy pp. 33-35

Christopher Doran and Joshua Byrnes

The efficiency of a volumetric alcohol tax in Australia pp. 37-49

Joshua Byrnes, Dennis Petrie, Christopher Doran and Anthony Shakeshaft

Tackling alcohol misuse pp. 51-63

Anne Ludbrook, Dennis Petrie, Lynda McKenzie and Shelley Farrar

Alcohol policy and taxation in South Africa pp. 65-76

John Ataguba

Volume 9, issue 6, 2011

Cost effectiveness of self-monitoring of blood glucose (SMBG) for patients with type 2 diabetes and not on insulin pp. 351-365

Sandra Tunis

Early retirement and income loss in patients with early and advanced Parkinson’s disease pp. 367-376

Scott Johnson, Matthew Davis, Anna Kaltenboeck, Howard Birnbaum, ElizaBeth Grubb, Marcy Tarrants and Andrew Siderowf

Excess costs associated with patients with chronic thromboembolic pulmonary hypertension in a US privately insured population pp. 377-387

Noam Kirson, Howard Birnbaum, Jasmina Ivanova, Tracy Waldman, Vijay Joish and Todd Williamson

An application of a proposed framework for formulary listing in low-income countries pp. 389-402

Vakaramoko Diaby and Jean Lachaine

A review of the cost effectiveness of bisphosphonates in the treatment of post-menopausal osteoporosis in Switzerland pp. 403-417

Kurt Lippuner, Richard Pollock, Jayne Smith-Palmer, Thomas Meury and William Valentine

Volume 9, issue 5, 2011

Nutrition therapy cost analysis in the US pp. 281-292

Robin Turpin, Todd Canada, Frank Liu, Catherine Mercaldi, Alessandro Pontes-Arruda and Paul Wischmeyer

Cost effectiveness of chemoprevention for prostate cancer with dutasteride in a high-risk population based on results from the REDUCE Clinical trial pp. 305-315

Michael Kattan, Stephanie Earnshaw, Cheryl McDade, Libby Black and Gerald Andriole

Early assessment of medical technologies to inform product development and market access pp. 331-347

Maarten Ijzerman and Lotte Steuten

Erratum to: Cost effectiveness of secondary vs tertiary prevention for post-menopausal osteoporosis pp. 348-348

D. Mueller and A. Gandjour

Volume 9, issue 4, 2011

Design of patient access schemes in the UK pp. 209-215

Szymon Jarosławski and Mondher Toumi

Cost-efficacy analysis of the MONET trial using UK antiretroviral drug prices pp. 217-223

Brian Gazzard, Andrew Hill and Anne Anceau

Ordering errors, objections and invariance in utility survey responses pp. 225-241

Eve Wittenberg and Lisa Prosser

The use of decision-analytic models in Parkinson’s disease pp. 243-258

James Shearer, Colin Green, Carl Counsell and John Zajicek

Cost effectiveness of secondary vs tertiary prevention for post-menopausal osteoporosis pp. 259-273

Dirk Mueller and Afschin Gandjour

Drugs for rare diseases: Influence of orphan designation status on price pp. 275-279

Eline Picavet, Marc Dooms, David Cassiman and Steven Simoens

Volume 9, issue 3, 2011

The economics of the NHS cancer drugs fund pp. 137-138

Alan Maynard and Karen Bloor

The impact of inclusion criteria in health economic assessments pp. 139-148

Anke Richter, Patricia Thieda, Kylie Thaler and Gerald Gartlehner

Valuing health at different ages pp. 149-156

Daniel Eisenberg, Gary Freed, Matthew Davis, Dianne Singer and Lisa Prosser

Assessing the performance of a new generic measure of health-related quality of life for children and refining it for use in health state valuation pp. 157-169

Katherine Stevens

Patent extension policy for paediatric indications pp. 171-181

Richard Nelson, Carrie McAdam-Marx, Megan Evans, Robert Ward, Benjamin Campbell, Diana Brixner and Joanne Lafleur

Cost effectiveness of tobacco control policies in Vietnam pp. 183-196

Hideki Higashi, Khoa Truong, Jan Barendregt, Phuong Nguyen, Mai Vuong, Thuy Nguyen, Phuong Hoang, Angela Wallace, Tien Tran, Cuong Le and Christopher Doran

Hospital costs, length of stay and mortality associated with childhood, adolescent and young Adult meningococcal disease in the US pp. 197-207

Keith Davis, Timothy Bell, Jacqueline Miller, Derek Misurski and Bela Bapat

Volume 9, issue 2, 2011

Germany’s decision rule for setting ceiling prices of drugs pp. 65-71

Afschin Gandjour

Public and decision maker stated preferences for pharmaceutical subsidy decisions pp. 73-79

Jennifer Whitty, Paul Scuffham and Sharyn Rundle-Thielee

Citizens’ preferences for brand name drugs for treating acute and chronic conditions pp. 81-87

Arina Denoth, Christophe Pinget and Jean-Blaise Wasserfallen

Influenza vaccination in healthy working adults in Russia pp. 89-99

O. At’kov, A. Azarov, D. Zhukov, N. Nicoloyannis and Laure Durand

Influence of patient co-payments on atypical antipsychotic choice in Poland pp. 101-110

Magda Wladysiuk, Aleksander Araszkiewicz, Brian Godman, Katarzyna Szabert, Corrado Barbui and Alan Haycox

Current and future economic burden of osteoporosis in New Zealand pp. 111-123

Paul Brown, Rob McNeill, William Leung, Eman Radwan and Jane Willingale

Impact of fibromyalgia severity on health economic costs pp. 125-136

Andreas Winkelmann, Serge Perrot, Caroline Schaefer, Kellie Ryan, Arthi Chandran, Alesia Sadosky and Gergana Zlateva

Volume 9, issue 1, 2011

The Chinese healthcare system pp. 1-13

Jens Hougaard, Lars Peter Østerdal and Yi Yu

Valuing child health utility 9D health states with a young adolescent sample pp. 15-27

Julie Ratcliffe, Leah Couzner, Terry Flynn, Michael Sawyer, Katherine Stevens, John Brazier and Leonie Burgess

Costs to hospitals of acquiring and processing blood in the US pp. 29-37

Richard Toner, Laura Pizzi, Brian Leas, Samir Ballas, Alyson Quigley and Neil Goldfarb

Determinants of out-of-pocket health expenditure in China pp. 39-49

Xuedan You and Yasuki Kobayashi

The impact of CT colonography for colorectal cancer screening on the UK NHS pp. 51-64

Alison Sweet, David Lee, Kerry Gairy, Denver Phiri, Timothy Reason and Kevin Lock